Clinic epidemiological evaluation of co morbidities in patients with psoriasis in a tertiary care hospital
Background: Psoriasis is a common disease presented to the dermatology clinics. There are several reports concerning co morbidities in patients with psoriasis. Some of them include diabetes mellitus, hypertension, dyslipidemia, obesity, IHD, ulcerative colitis. Hence, we in the present study tri...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Prathima Institute of Medical Sciences
2020-12-01
|
| Series: | Perspectives In Medical Research |
| Subjects: | |
| Online Access: | https://www.pimr.org.in/2020-vol8-issue-3/originalarticle1_v1.pdf |
| Summary: | Background: Psoriasis is a common disease presented to the
dermatology clinics. There are several reports concerning co
morbidities in patients with psoriasis. Some of them include
diabetes mellitus, hypertension, dyslipidemia, obesity, IHD,
ulcerative colitis. Hence, we in the present study tried to
evaluate the existing comorbidities in patients diagnosed with
psoriasis in presenting to our hospital.
Methods: This study was conducted in the Department of
Dermatology, Venereology, and Leprosy, Prathima Institute of
Medical Sciences, Karimnagar. This case-control study
evaluated the prevalence of diabetes mellitus, hypertension,
obesity, dyslipidemia and metabolic syndrome in patients with
psoriasis. The existence of hypertension, diabetes mellitus,
dyslipidemia, obesity was determined by standard criteria. The
data was recorded and analyzed using SPSS version 17 for p
values.
Results: BSL (Blood Sugar Level) derangement as increased
fasting BSL was observed in 23 (23%) cases compared to 8(8%)
controls. There was a statistically significant difference between
psoriatic cases and controls. The total number of male patients
with raised waist circumference was 24 (33.8%) compared to
9(13.2%) controls. There was a statistically significant
association of raised waist circumference in psoriasis cases
compared to controls, the p-value was <0.004. The existence
of metabolic syndrome was 27% in the study group and 8% in
the control group the p values were <0.004 and significant.
Conclusion: The results of the present shows that there is a
significant prevalence of psoriasis in males as compared to
females. There is a significant association of metabolic
syndrome in patients with psoriasis. Hence all the patients with
psoriasis need to be evaluated for metabolic syndrome which
may be a risk factor for systemic diseases |
|---|---|
| ISSN: | 2348-1447 2348-229X |